Biomatlante Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
32
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$11.3M
Biomatlante General Information
Description
Developer of bone graft technologies intended for bone regeneration. The company develops, manufactures, and commercializes synthetic biomaterials for bone regeneration used in orthopedics, spine, dental, stomatology, and trauma surgery, thereby enabling doctors to access synthetic biomaterials for bone tissue care.
Contact Information
Website
www.biomatlante.com(Operating Subsidiary)
Corporate Office
- ZA Les Quatre Nations
- 5 Rue Edouard Belin
- 44360 Vigneux-de-Bretage
- France
Corporate Office
- ZA Les Quatre Nations
- 5 Rue Edouard Belin
- 44360 Vigneux-de-Bretage
- France
Biomatlante Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 30-Nov-2019 | $11.3M | Completed | Generating Revenue | ||
| 3. Grant | 01-Oct-2016 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series A) | 28-Sep-2009 | $5.11M | $5.11M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Biomatlante Comparisons
Industry
Financing
Details
Biomatlante Competitors (8)
One of Biomatlante’s 8 competitors is Geistlich Pharma, a Corporation company based in Wolhusen, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Geistlich Pharma | Corporation | Wolhusen, Switzerland | ||||
| Bonalive Biomaterials | Corporation | Turku, Finland | ||||
| CoreBone | Venture Capital-Backed | Misgav, Israel | ||||
| Teknimed | Private Equity-Backed | L'Union, France | ||||
| IlluminOss | Private Equity-Backed | East Providence, RI |
Biomatlante Patents
Biomatlante Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3031479-A1 | Compositions for bone reconstruction | Inactive | 12-Dec-2014 | ||
| FR-2937872-B1 | Bone filling with high mechanical strength. | Inactive | 31-Oct-2008 | ||
| FR-2937872-A1 | Product, useful as bone substitute, comprises biocompatible and extrudable filling biomaterial and biocompatible and injectable biomaterial in gel/paste form, as combined preparation for simultaneous/sequential use to fill bony defect | Active | 31-Oct-2008 | ||
| FR-2922454-A1 | Bone substitute comprising a contrast agent, process for preparing the same and uses thereof | Active | 22-Oct-2007 | ||
| FR-2922454-B1 | Bone substitute comprising a contrast agent, process for preparing the same and uses thereof | Inactive | 22-Oct-2007 | A61K49/0409 |
Biomatlante Signals
Biomatlante Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlanpole | Accelerator/Incubator | |||
| European Union | Government | |||
| Seventure | Venture Capital | Minority |
Biomatlante FAQs
-
When was Biomatlante founded?
Biomatlante was founded in 1995.
-
Where is Biomatlante headquartered?
Biomatlante is headquartered in Vigneux-de-Bretage, France.
-
What is the size of Biomatlante?
Biomatlante has 32 total employees.
-
What industry is Biomatlante in?
Biomatlante’s primary industry is Medical Supplies.
-
Is Biomatlante a private or public company?
Biomatlante is a Private company.
-
What is the current valuation of Biomatlante?
The current valuation of Biomatlante is .
-
What is Biomatlante’s current revenue?
The current revenue for Biomatlante is .
-
How much funding has Biomatlante raised over time?
Biomatlante has raised $5.11M.
-
Who are Biomatlante’s investors?
Atlanpole, European Union, and Seventure have invested in Biomatlante.
-
Who are Biomatlante’s competitors?
Geistlich Pharma, Bonalive Biomaterials, CoreBone, Teknimed, and IlluminOss are some of the 8 competitors of Biomatlante.
-
When was Biomatlante acquired?
Biomatlante was acquired on 30-Nov-2019.
-
Who acquired Biomatlante?
Biomatlante was acquired by Advanced Medical Solutions Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process